Annual Short Term Debt
$6.16 M
+$575.00 K+10.30%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual short term debt is $6.16 million, with the most recent change of +$575.00 thousand (+10.30%) on December 31, 2023.
- During the last 3 years, ABCL annual short term debt has risen by +$5.48 million (+812.30%).
- ABCL annual short term debt is now at all-time high.
Performance
ABCL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$5.13 M
-$478.00 K-8.53%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly short term debt is $5.13 million, with the most recent change of -$478.00 thousand (-8.53%) on September 30, 2024.
- Over the past year, ABCL quarterly short term debt has dropped by -$478.00 thousand (-8.53%).
- ABCL quarterly short term debt is now -16.77% below its all-time high of $6.16 million, reached on December 31, 2023.
Performance
ABCL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ABCL Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.3% | -8.5% |
| 3 y3 years | +812.3% | +83.0% |
| 5 y5 years | +143.3% | +77.6% |
ABCL Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.6% | -16.8% | +40.3% |
| 5 y | 5-year | at high | +812.3% | -16.8% | +1503.6% |
| alltime | all time | at high | +812.3% | -16.8% | +1503.6% |
AbCellera Biologics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.13 M(-8.5%) |
| Jun 2024 | - | $5.60 M(+1.3%) |
| Mar 2024 | - | $5.53 M(-10.2%) |
| Dec 2023 | $6.16 M(+10.3%) | $6.16 M(+10.5%) |
| Sep 2023 | - | $5.57 M(-6.4%) |
| Jun 2023 | - | $5.95 M(+1.4%) |
| Mar 2023 | - | $5.87 M(+5.1%) |
| Dec 2022 | $5.58 M | $5.58 M(+23.6%) |
| Sep 2022 | - | $4.52 M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.02 M(+2.6%) |
| Mar 2022 | - | $3.92 M(+7.3%) |
| Dec 2021 | $3.65 M(+441.0%) | $3.65 M(+30.4%) |
| Sep 2021 | - | $2.80 M(+26.1%) |
| Jun 2021 | - | $2.22 M(+44.8%) |
| Mar 2021 | - | $1.53 M(+127.1%) |
| Dec 2020 | $675.00 K(-76.6%) | $675.00 K(+111.2%) |
| Sep 2020 | - | $319.60 K(-88.9%) |
| Dec 2019 | $2.89 M(+14.0%) | $2.89 M |
| Dec 2018 | $2.53 M | - |
FAQ
- What is AbCellera Biologics annual short term debt?
- What is the all time high annual short term debt for AbCellera Biologics?
- What is AbCellera Biologics annual short term debt year-on-year change?
- What is AbCellera Biologics quarterly short term debt?
- What is the all time high quarterly short term debt for AbCellera Biologics?
- What is AbCellera Biologics quarterly short term debt year-on-year change?
What is AbCellera Biologics annual short term debt?
The current annual short term debt of ABCL is $6.16 M
What is the all time high annual short term debt for AbCellera Biologics?
AbCellera Biologics all-time high annual short term debt is $6.16 M
What is AbCellera Biologics annual short term debt year-on-year change?
Over the past year, ABCL annual short term debt has changed by +$575.00 K (+10.30%)
What is AbCellera Biologics quarterly short term debt?
The current quarterly short term debt of ABCL is $5.13 M
What is the all time high quarterly short term debt for AbCellera Biologics?
AbCellera Biologics all-time high quarterly short term debt is $6.16 M
What is AbCellera Biologics quarterly short term debt year-on-year change?
Over the past year, ABCL quarterly short term debt has changed by -$478.00 K (-8.53%)